Refine by
Blood Tissue Articles & Analysis: Older
21 news found
Biomedical Polymers Biomedical polymers have and still continue to play an important role in how we support and treat patients with various diseases through their use in tissue and blood interacting medical devices and drug delivery systems. ...
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. ...
Alume Bioscience’s CEO and founder Quyen Nguyen, MD/PhD, stated, “As surgeons, we rely on our experience to identify nerves, but often they are buried or appear indistinguishable from adjacent non-nerve tissue. This study aims to demonstrate improvement of surgical precision by making nerves ‘glow’ with fluorescence. ...
As part of this grant, breast surgeon collaborators will use OnLume’s imaging device for intraoperative visualization and assessment of small lymphatic tissue and blood vessels. The FGS imaging system may help reduce the risk of two breast cancer-related morbidities, lymphedema and tissue necrosis. ...
The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This intraoperative imaging technology is used in conjunction with the FDA approved indocyanine green (ICG) dye with applications to several ...
The study incorporated the use of the Activ Surgical intraoperative surgical intelligence and the proprietary ActivPerfusion™ visualization mode that allows for dye-free detection and display of tissue perfusion and real-time imperceptible latency. “My peers and I are very pleased with the results of this IRB study using Activ Surgical enhanced visualization,” ...
Sonavex scored FDA clearance for its technology that uses ultrasound imaging and deep learning to deliver blood flow data on demand. The EchoSure system is cleared for use with the company’s EchoMark bioresorbable tissue markers, which got the agency’s nod in June. ...
Known as a supplier of a full range of materials, Alfa Chemistry Materials never forgets its mission to bring the newly emerged novel materials to customers, and now presents itself as a provider of biomaterials, which can be used as blood compatibility materials, soft tissue compatibility materials, hard histocompatibility material, biodegradable materials as ...
"Physicians often tell us they are impressed by how well our structural heart solution simulates the feel, friction, and haptic feedback of real heart tissue and blood vessels. Simulating valve movement goes well beyond that -- and will take our solution to the next level. We are essentially delivering a complex system that replicates a beating heart with valves ...
ByBIOMODEX
The test looks for hundreds of biomarkers in a small amount of tumor tissue, including complex genomic signatures like tumor mutational burden (TMB), homologous recombination deficiency (HRD) and microsatellite instability (MSI) that can determine whether immunotherapy or PARP inhibitors would work for a patient. Patients will also undergo the OncoFOLLOW™ liquid biopsy ...
If at least 1 of 5 demonstrates the presence of LB-100 in tumor tissue, 3 additional subjects will be enrolled. If at least 2 of the 8 patients demonstrate LB-100 in tumor tissue, the study will be considered significant providing further support for studying if the addition of LB-100 to standard treatment regimens for malignant brain tumors improves outcomes. ...
HemoShear and Takeda are continuing their collaboration under a second agreement established in October 2020 to develop a new human tissue-based model of a rare liver disease using the REVEAL-Tx™ Platform. ...
Previously exclusive to X-ZELL, the patented system is part of the company’s single-cell diagnostics platform, which is capable of isolating and visualising individual atypical cells from a small 10mL blood sample. According to X-ZELL’s Head of Engineering & Product Development, Sven Strache, the technology is crucial to the routine discovery of next-generation ...
X-ZELL’s modular system can be seamlessly integrated into routine pathology and is capable of visualising ultra-rare, atypical cells in a small, 10mL blood sample. Research has shown that these cells could help physicians diagnose clinically significant cancers at the earliest stages without putting patients at risk. ...
No other critical care blood gas analyzer has this unique capability. Low MCHC, associated with hypochromic anemias, can indicate internal bleeding, anemia of chronic disease, chronic low grade blood loss, iron deficiency, and thalassemia. ...
The technology is cleared for fluorescence imaging of blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, reconstructive and microsurgeries. OnLume is developing further applications of its imaging platform, including FGS for cancer surgery in which tumor-specific drugs could deliver fluorescent agents ...
Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. ...
These materials do not permanently occlude blood vessels supplying healthy tissue and may allow for better restoration of artery integrity after embolization compared to permanent microspheres and gels. ...
There are multiple interactions between tissue and sound waves as they travel into the body and back again to produce the final image. ...
Expression Analysis offers solutions for challenging specimens such as whole blood and FFPE tissues, as well as nucleic acid isolation and data analysis services. ...